2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization …

M Glikson, JC Nielsen, MB Kronborg, Y Michowitz… - EP …, 2022‏ - academic.oup.com
for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines …

2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction

FM Kusumoto, MH Schoenfeld, BL Wilkoff… - Heart …, 2017‏ - heartrhythmjournal.com
From the 1Mayo Clinic, Jacksonville, Florida, 2Yale University School of Medicine, New
Haven, Connecticut, 3Cleveland Clinic Lerner College of Medicine of Case Western …

A dual-chamber leadless pacemaker

RE Knops, VY Reddy, JE Ip, R Doshi… - … England Journal of …, 2023‏ - Mass Medical Soc
Background Single-chamber ventricular leadless pacemakers do not support atrial pacing or
consistent atrioventricular synchrony. A dual-chamber leadless pacemaker system …

JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias

A Nogami, T Kurita, H Abe, K Ando, T Ishikawa… - Circulation …, 2021‏ - jstage.jst.go.jp
Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of …

FM Kusumoto, MH Schoenfeld, C Barrett… - Journal of the American …, 2019‏ - jacc.org
The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …

European heart rhythm association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections …

C Blomström-Lundqvist, V Traykov… - European Journal of …, 2020‏ - academic.oup.com
Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy
devices are potentially life-saving treatments for a number of cardiac conditions, but are not …

[HTML][HTML] Updated performance of the Micra transcatheter pacemaker in the real-world setting: a comparison to the investigational study and a transvenous historical …

MF El-Chami, F Al-Samadi, N Clementy, C Garweg… - Heart rhythm, 2018‏ - Elsevier
Background Early results of the Micra Investigational Device Exemption (IDE) study and
Micra Post-Approval Registry (PAR) demonstrated excellent safety and efficacy …

Leadless vs. transvenous single-chamber ventricular pacing in the Micra CED study: 2-year follow-up

MF El-Chami, L Bockstedt, C Longacre… - European Heart …, 2022‏ - academic.oup.com
Aims Clinical trials have demonstrated the safety and efficacy of the Micra leadless VVI
pacemaker; however, longer-term outcomes in a large, real-world population with a …

A decade of information on the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology …

MJP Raatikainen, DO Arnar, B Merkely… - Ep …, 2017‏ - academic.oup.com
Aims The aim of this analysis was to provide comprehensive information on invasive cardiac
arrhythmia therapies in the European Society of Cardiology (ESC) area over the past 10 …

[HTML][HTML] A leadless pacemaker in the real-world setting: the Micra Transcatheter Pacing System Post-Approval Registry

PR Roberts, N Clementy, F Al Samadi, C Garweg… - Heart rhythm, 2017‏ - Elsevier
Background First-in-man studies of leadless pacemakers have demonstrated high rates of
implant success, and safety and efficacy objectives were achieved. Outside of the …